(Q38086121)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23456539%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

title

Cancer-related coagulopathy (Trousseau's syndrome): review of the literature and experience of a single center of internal medicine (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23456539%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

0 references

1 reference

blood coagulation disease

1 reference

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23456539%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Vito Racanelli

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23456539%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

author name string

Franco Dammacco

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23456539%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Angelo Vacca

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23456539%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Pasquale Procaccio

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23456539%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Ilaria Marech

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23456539%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

language of work or name

1 reference

2 March 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23456539%20AND%20SRC:MED&resulttype=core&format=json

Clinical and Experimental Medicine

24 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23456539%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

volume

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23456539%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23456539%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

page(s)

85-97

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23456539%20AND%20SRC:MED&resulttype=core&format=json

Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based study

24 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS10238-013-0230-0

The Worcester Venous Thromboembolism study: a population-based study of the clinical epidemiology of venous thromboembolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-013-0230-0

Epidemiology and predictors of short-term mortality in symptomatic venous thromboembolism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-013-0230-0

Epidemiology and pathophysiology of cancer-associated thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-013-0230-0

Thrombotic complications in adult patients with lymphoma: a meta-analysis of 29 independent cohorts including 18 018 patients and 1149 events

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-013-0230-0

Rates of initial and recurrent thromboembolic disease among patients with malignancy versus those without malignancy. Risk analysis using Medicare claims data

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-013-0230-0

Venous Thromboembolism Associated With Long-Term Use of Central Venous Catheters in Cancer Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-013-0230-0

Novel assays of thrombogenic pathogenicity in the antiphospholipid syndrome based on the detection of molecular oxidative modification of the major autoantigen β2-glycoprotein I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-013-0230-0

Air travel and the risk of thromboembolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-013-0230-0

Risk factors for deep vein thrombosis and pulmonary embolism: a population-based case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-013-0230-0

21 January 2018

Thrombosis and cancer

1 reference

https://api.crossref.org/works/10.1007%2FS10238-013-0230-0

Incidence of venous thromboembolism in the year before the diagnosis of cancer in 528,693 adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-013-0230-0

Electronic alerts to prevent venous thromboembolism among hospitalized patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-013-0230-0

High plasma levels of soluble P-selectin are predictive of venous thromboembolism in cancer patients: results from the Vienna Cancer and Thrombosis Study (CATS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-013-0230-0

Predictors of recurrence after deep vein thrombosis and pulmonary embolism: a population-based cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-013-0230-0

Association between venous and arterial thrombosis: clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-013-0230-0

Venous thromboembolism and arterial complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-013-0230-0

Trousseau syndrome due to pleural mesothelioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-013-0230-0

Cancer and venous thromboembolism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-013-0230-0

International recommendations for the prevention and treatment of venous thromboembolism associated with cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-013-0230-0

New therapies in multiple myeloma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-013-0230-0

Prospective evaluation of coagulopathy in multiple myeloma patients before, during and after various chemotherapeutic regimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-013-0230-0

Lenalidomide in multiple myeloma: current experimental and clinical data.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-013-0230-0

Current treatment strategies with lenalidomide in multiple myeloma and future perspectives.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-013-0230-0

Risk of venous thromboembolism with the angiogenesis inhibitor bevacizumab in cancer patients: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-013-0230-0

Venous thromboembolic events with chemotherapy plus bevacizumab: a pooled analysis of patients in randomized phase II and III studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-013-0230-0

Venous thromboembolism and mortality associated with recombinant erythropoietin and darbepoetin administration for the treatment of cancer-associated anemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-013-0230-0

Recombinant human erythropoietins and cancer patients: updated meta-analysis of 57 studies including 9353 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-013-0230-0

Effects of erythropoietin receptors and erythropoiesis-stimulating agents on disease progression in cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-013-0230-0

Clustering of venous thrombosis events at the start of tamoxifen therapy in breast cancer: a population-based experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-013-0230-0

The risk of venous thromboembolic disease associated with adjuvant hormone therapy for breast carcinoma: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-013-0230-0

Thrombotic risks of oral contraceptives

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-013-0230-0

Cancer and contraception. Release date May 2012. SFP Guideline #20121.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-013-0230-0

An overview of coagulation disorders in cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-013-0230-0

Tissue factor in cancer and angiogenesis: the molecular link between genetic tumor progression, tumor neovascularization, and cancer coagulopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-013-0230-0

Endothelial cell diversity revealed by global expression profiling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-013-0230-0

Valves of the deep venous system: an overlooked risk factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-013-0230-0

Cancers predispose neutrophils to release extracellular DNA traps that contribute to cancer-associated thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-013-0230-0

Procoagulant activity in hemostasis and thrombosis: Virchow's triad revisited

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-013-0230-0

Secondary prophylaxis with warfarin for venous thromboembolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-013-0230-0

21 January 2018

Emerging anticoagulants

1 reference

https://api.crossref.org/works/10.1007%2FS10238-013-0230-0

An indirect comparison of dabigatran, rivaroxaban and apixaban for atrial fibrillation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-013-0230-0

Meta-analysis of efficacy and safety of new oral anticoagulants (dabigatran, rivaroxaban, apixaban) versus warfarin in patients with atrial fibrillation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-013-0230-0

Aspirin for dual prevention of venous and arterial thrombosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-013-0230-0

Low-dose aspirin for preventing recurrent venous thromboembolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-013-0230-0

International clinical practice guidelines for the treatment and prophylaxis of thrombosis associated with central venous catheters in patients with cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10238-013-0230-0

International clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer.

21 January 2018

1 reference

12 December 2020

Frequency, demographics and risk (according to tumour type or site) of cancer-associated thrombosis among patients seen at outpatient DVT clinics

1 reference

12 December 2020

Derivation and validation of a simple model to identify venous thromboembolism risk in medical patients

1 reference

12 December 2020

New agents in medical oncology and the risk of venous thromboembolism

1 reference

12 December 2020

Identifying acutely ill medical patients requiring thromboprophylaxis

1 reference

12 December 2020

Apixaban for extended treatment of venous thromboembolism

1 reference

12 December 2020

The risk of a venous thrombotic event in lung cancer patients: higher risk for adenocarcinoma than squamous cell carcinoma

1 reference

12 December 2020

Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years' adjuvant treatment for breast cancer.

1 reference

12 December 2020

Massive venous thrombosis of inferior vena cava as primary manifestation of renal Ewing's sarcoma.

1 reference

12 December 2020

Tumor grade is associated with venous thromboembolism in patients with cancer: results from the Vienna Cancer and Thrombosis Study

1 reference

12 December 2020

Lack of prophylaxis before the onset of acute venous thromboembolism among hospitalized cancer patients: the SWIss Venous ThromboEmbolism Registry (SWIVTER)

1 reference

12 December 2020

10.1007/S10238-013-0230-0

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23456539%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

24 February 2020

1010666953

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23456539%20AND%20SRC:MED&resulttype=core&format=json